Eleven Years of Antidepressants, and Nobody Checked Her Metabolic Health
Your brain is an organ, it runs on fuel, and when the fuel system breaks mood is often the first thing to show it.
She had been on antidepressants for eleven years. Four different ones, two augmentation strategies, a course of therapy. She came in for hormones, and somewhere in the intake she said the thing I hear most often in that chair.
"I just want to feel like myself again."
Her chart held a decade of competent psychiatric care. It did not hold a single fasting insulin. Not one Free T3 level. Her thyroid had been checked, in the sense that a TSH was drawn once and called normal, so her symptoms were assumed unrelated. Those are two different sentences.
I do not think her prescribers were careless. The evidence connecting metabolism to mental health has piled up in a place where a psychiatrist has no reason to look and an endocrinologist has no reason to act.
Your brain is the most expensive organ you own
It is about two percent of your body weight and it burns roughly twenty percent of your energy. Every thought, every mood, every night of real sleep is paid for in fuel, and that fuel is made by mitochondria inside your cells.
Three systems run that fuel line.
Insulin does more than manage blood sugar. It crosses into the brain and acts on the circuits that handle motivation, appetite and sleep. Thyroid hormone is the master regulator: it sets how fast every cell runs, and it does two things to mitochondria specifically, building new ones and clearing out the damaged ones. Estradiol starts inside mitochondria and acts back on them, which is why the menopause transition changes how a brain makes energy and not only how a body feels.
When that fuel line degrades, the brain is the organ that notices first. That is the whole idea of metabolic psychiatry, set out by the Harvard psychiatrist Christopher Palmer, and it is why so often the same person is carrying a mood diagnosis in one clinic and a metabolic one in another, with nobody connecting them.
The metabolic problem tends to arrive first
Swedish researchers followed more than two hundred thousand adults for about twenty years. Higher fasting glucose and higher triglycerides tracked with later depression, anxiety and stress-related diagnoses, and higher HDL ran the other way and was protective. Then they looked backward from each diagnosis and found those numbers had already been drifting for two decades before anyone was diagnosed with anything.
British researchers followed children from age one to twenty-four and found something more precise. The children whose insulin ran high from age nine carried the risk of psychosis. The children who gained the most weight around puberty carried the risk of depression. Two different metabolic signals, two different destinations, both of them years ahead of the diagnosis.
What happens when you correct it
Thyroid. Adding T3 to an antidepressant raised response from fifty percent to seventy in a randomized trial, without a meaningful increase in side effects. In that trial the patients who improved had started with lower T3 than the ones who did not, every one of them already called thyroid-normal. The authors looked for a cutoff you could use in clinic and could not find one, and a larger trial did not repeat the pattern, so I draw the number and I do not over-read it. Psychiatry has been using thyroid hormone this way since the 1930s without being able to say why it works. More mitochondria, working better, is a reason.
Estradiol. Women in the menopause transition who were not depressed were given estradiol by patch or a placebo patch for a year. The hormone roughly halved the number who went on to become depressed. It worked in women in the early transition and not in women further past it, which is the clearest argument I know of for acting during the window instead of waiting for someone to get sick. The frightening headlines were about a different drug. That trial used estradiol, the same molecule the ovary makes. The studies that scared a generation off hormones used conjugated equine estrogen paired with a synthetic progestin.
DHEA. In midlife depression, DHEA beat placebo on its own, as the only treatment rather than as an add-on. And in people whose adrenal glands cannot make DHEA at all, replacing it back into the normal adult range lifted mood and fatigue.
Testosterone. Two trials look like they disagree, and they do not. Men who were genuinely low improved. Women who were not selected for being low, and were given more anyway, did not. Replacing what is missing works. Topping up what is already there does not.
That last line is the principle underneath all of it. These are not drugs being added to a body. They are molecules being put back.
A basic lab draw to start with
This is a starting point, not the whole panel. I draw more than this. These are the ones I would not leave undrawn in someone treated for a mood disorder for a decade, and none of them are exotic or expensive.
Free T3 (above 4.0) and TSH.
Total and free testosterone, in both men and women.
Sex hormone binding globulin (above 100).
DHEA-S.
Triglycerides and HDL. Under 50 is ideal for triglycerides, 60 or better for HDL, and the ratio of the two under 1.5.
Fasting insulin (under 5) and glucose, with HOMA-IR. Insulin climbs before glucose does, so insulin is the earlier signal and the one usually missing from the chart.
FSH and LH.
Vitamin B12 (above 1000).
Iron and ferritin (above 75).
Progesterone.
A number inside the reference range is not the same as a number that is right for you. That is the gap this whole article lives in.
What this does not mean
Nothing here is a reason to stop an antidepressant. If one is working, it is working, and psychiatric medications are genuinely dangerous to change without supervision. This is about what should have been drawn alongside.
Hormones do not fix everything either. There is no single lab that explains a life, and optimizing a metabolic panel will not replace psychiatric care in someone who needs it.
The part worth changing
A decade of good care, and the cheapest tests in medicine had never been run once.
That is not a failure of her doctors. It is a failure of where the evidence currently sits, and it is fixable this afternoon by drawing a panel.
⚠️ Educational content, not individual medical advice, diagnosis or a treatment recommendation. Nobody should start, stop or change a prescription because of an article, least of all a psychiatric one. Your own labs and history belong in a one on one.
If you are in crisis in the US, call or text 988. Anywhere else, use your local emergency number. Do not wait for a lab result.
🩺 DNP led telehealth hormone optimization. If you want these drawn and interpreted in context rather than against a reference range alone, that is the conversation we have here: withinyou.health/links
Luke Swift, DNP · Within You Therapeutics
Sources
Chourpiliadis C, et al. Metabolic profile and long-term risk of depression, anxiety, and stress-related disorders. JAMA Netw Open. 2024;7(4):e244525.
Cooper-Kazaz R, et al. Combined treatment with sertraline and liothyronine in major depression. Arch Gen Psychiatry. 2007;64:679-688.
Dichtel LE, et al. Low-dose testosterone augmentation for antidepressant-resistant major depressive disorder in women. Am J Psychiatry. 2020;177(10):965-973.
Garlow SJ, et al. The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder. J Psychiatr Res. 2012;46(11):1406-1413.
Gordon JL, et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition. JAMA Psychiatry. 2018;75(2):149-157.
Hunt PJ, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease. J Clin Endocrinol Metab. 2000;85:4650-4656.
Kelly T. A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis. J Affect Disord. 2014;166:353-358.
Palmer CM. Brain Energy. Dallas, TX: BenBella Books; 2022.
Perry BI, et al. Longitudinal trends in childhood insulin levels and body mass index and associations with risks of psychosis and depression in young adults. JAMA Psychiatry. 2021;78(4):416-425.
Pope HG, et al. Testosterone gel supplementation for men with refractory depression. Am J Psychiatry. 2003;160(1):105-111.
Schmidt PJ, et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005;62:154-162.
